
Advertise on podcast: The Lancet HIV in conversation with
Rating
5from
This podcast has
62 episodes
Language
EnglishPublisher
The Lancet GroupExplicit
No
Date created
2020/05/04
Latest episode
2025/12/09
Average duration
25 min.
Release period
32 days
Description
Peter Hayward, Editor-in-Chief, and Adrian Gonzalez-Lopez, Senior Editor at The Lancet HIV, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from treatments of children with HIV to COVID-19 and chemsex, the experiences of HIV among global Indigenous populations to intimate partner violence and women with HIV, and more.
Unlock The Lancet HIV in conversation with podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check The Lancet HIV in conversation with social media presence
Podcast episodes
Check latest episodes from The Lancet HIV in conversation with podcast
Solange Baptiste, Charles Holmes, and Kenneth Ngure on sustainable HIV prevention in Africa
2025/12/09
Controlling the HIV epidemic depends on shifting from fragmented, donor-led programmes to nationally led, integrated health systems. To accompany a new joint Series of six papers, Peter Hayward, Editor-in-chief of The Lancet HIV, and Gavin Cleaver, Senior Editor at The Lancet Global Health, are joined in conversation by Solange Baptiste, Kenneth Ngure, and Charles Holmes, who worked extensively on the Series.
Together they discuss withstanding external funding shocks, meaningful community involvement, and focusing on health equity, as part of a sustainable approach to HIV prevention in Africa.
Click here to read the full series: https://www.thelancet.com/series-do/sustainable-hiv-prevention-africa
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Luxena Sukumaran and Alan Winston on disordered sleep in people living with HIV
2025/11/26
Why do some people living with HIV struggle with sleep? Luxena Sukuraman and Alan Winston help us understand the challenges of disordered sleep in HIV, what clinicians can do to help, and practical sleep hygiene tips for people living with HIV experiencing sleep disturbances.
Click here to read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00221-8/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Deborah Persaud on the possibility of HIV remission in neonates
2025/11/04
In the ongoing search for an HIV cure, promising evidence suggests that early treatment of infants might help achieve lasting HIV remission: the IMPAACT P1115 study is designed to investigate that potential. We talk to a lead investigator about what we know so far.
Read the full article: www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00189-4/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Jayne Ellis on cytomegalovirus and Epstein–Barr virus in people with HIV-associated cryptococcal meningitis
2025/10/01
Despite advances in treatment, HIV-associated cryptococcal meningitis continues to carry a high risk of death in Africa. In this episode, Jayne Ellis from the London School of Hygiene and Tropical Medicine discusses new research showing why targeting cytomegalovirus could be key to improving outcomes for people living with advanced HIV.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Maggie Walters and Michelle Bulterys on the probability of vertical transmission of HIV
2025/08/28
Although some countries are making great headway in eliminating vertical transmission of HIV, more than 100 000 infants acquire HIV each year. Maggie Walters and Michelle Bulterys talk us through their research into factors that affect the probability of vertical transmission and what it says about efforts to end new infant acquisitions.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00132-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Mansoor Farahani, Wafaa El-Sadr, and Wilford Kirungi on the progress in the HIV response in Uganda
2025/07/30
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
2025/07/01
In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Grace Lui and Vincent Wong on lifestyle modifications to address MASLD in people with HIV
2025/05/27
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease and has become the second leading cause of non-AIDS-related mortality in people living HIV. Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00032-3?dgcid=buzzsprout_icw_podcast_May_25_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Debra ten Brink and Rowan Martin-Hughes on the effects of international aid cuts on HIV acquisitions and mortality
2025/04/30
Could cuts to international aid by the world's richest nations really undo 30 years of progress in combatting the HIV pandemic?
Join Peter Hayward in conversation with Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00074-8/fulltext?dgcid=buzzsprout_icw_podcast_30-04-25_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Sari Reisner on the benefits of gender-affirming hormone therapy on HIV clinical outcomes
2025/03/27
Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.
Read the article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00004-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
And the personal view:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00299-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Lisa Noguchi and Nyaradzo Mgodi on HIV prophylactic dapivirine ring in breastfeeding women
2025/03/11
Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00306-0?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Sharon Lewin on requirements of a cell- and gene-based therapy product for HIV cure
2025/02/04
Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.
Read the full article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00277-7/fulltext?dgcid=buzzsprout_icw_podcast_general_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Claudia Cortes y Giovanni Ravasi sobre VIH y migración (in Spanish)
2024/12/05
Please note: this podcast is entirely in Spanish
Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH.
Lea la Serie completa:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00233-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Florence Riako Anam and Bruce Richman on U=U
2024/11/14
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.
Read the full Article:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00241-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Read related content here:
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30132-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(19)30226-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(20)30341-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Peter Hayward on 10 years of The Lancet HIV
2024/09/30
Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV.
Read this month´s anniversary editorial here: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(24)00245-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhiv
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Podcast reviews
Read The Lancet HIV in conversation with podcast reviews
Podcast sponsorship advertising
Start advertising on The Lancet HIV in conversation with relevant audience podcasts
You may also like to advertise on these Podcasts

4.3401063
Preston Scott Show
100.7 WFLA (WFLA-FM)

4.63201175
Success Story with Scott D. Clary
Success Story Media

4.9865198
Experience God with Bishop Dale C. Bronner
Bishop Dale C. Bronner

4.815649
Rev Lee Wolak Podcast
Rev Lee Wolak

4.5167315
The Real Science of Sport Podcast
Professor Ross Tucker and Mike Finch

4.9162565
Business of Story
Park Howell, Brand Story Strategist

4.9199410
After Class Podcast
Ronald D. Peters, John C. Nugent, Samuel C. Long

4.61208777
The CultCast
America's favorite Apple Podcast

4.9491801
Calmer in 5
Thom Walters

4.8208149
Fixable
TED

